Proteins > Neuropeptide Y receptor type 1
Page last updated: 2024-08-07 16:18:23
Neuropeptide Y receptor type 1
A neuropeptide Y receptor type 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P25929]
Synonyms
NPY1-R
Research
Bioassay Publications (21)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (9.52) | 18.2507 |
2000's | 9 (42.86) | 29.6817 |
2010's | 9 (42.86) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Compounds (10)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
bibp 3226 | Homo sapiens (human) | Kd | 0.0021 | 1 | 1 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
bibp 3226 | Homo sapiens (human) | Kb | 0.0015 | 4 | 4 |
bms 193885 | Homo sapiens (human) | Kb | 0.0045 | 1 | 1 |
N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time.Journal of medicinal chemistry, , Nov-25, Volume: 58, Issue:22, 2015
Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.Bioorganic & medicinal chemistry, , Nov-01, Volume: 21, Issue:21, 2013
Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
N(G)-Acyl-argininamides as NPY Y(1) receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor.Journal of natural products, , Volume: 72, Issue:12, 2009
Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist.Journal of medicinal chemistry, , Dec-25, Volume: 51, Issue:24, 2008
Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.Bioorganic & medicinal chemistry, , Nov-15, Volume: 16, Issue:22, 2008
Dihydropyridine neuropeptide Y Y(1) receptor antagonists.Bioorganic & medicinal chemistry letters, , Feb-11, Volume: 12, Issue:3, 2002
Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists.Journal of medicinal chemistry, , Nov-07, Volume: 40, Issue:23, 1997
Novel dihydropyrazine analogues as NPY antagonists.Bioorganic & medicinal chemistry letters, , Feb-11, Volume: 12, Issue:3, 2002
Dihydropyridine neuropeptide Y Y(1) receptor antagonists.Bioorganic & medicinal chemistry letters, , Feb-11, Volume: 12, Issue:3, 2002
Ligands of the neuropeptide Y Y2 receptor.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 24, Issue:2, 2014
A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 17, Issue:7, 2007
Heterodimeric Analogues of the Potent Y1R Antagonist 1229U91, Lacking One of the Pharmacophoric C-Terminal Structures, Retain Potent Y1R Affinity and Show Improved Selectivity over Y4R.Journal of medicinal chemistry, , 05-28, Volume: 63, Issue:10, 2020
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.Journal of medicinal chemistry, , Nov-27, Volume: 51, Issue:22, 2008
Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist.Journal of medicinal chemistry, , Dec-25, Volume: 51, Issue:24, 2008
Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine.Journal of medicinal chemistry, , Sep-07, Volume: 43, Issue:18, 2000
Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions.Journal of medicinal chemistry, , Nov-26, Volume: 36, Issue:24, 1993
Enables
This protein enables 6 target(s):
Target | Category | Definition |
peptide YY receptor activity | molecular function | Combining with gut peptide YY to initiate a change in cell activity. [PMID:9315606] |
pancreatic polypeptide receptor activity | molecular function | Combining with pancreatic polypeptide PP to initiate a change in cell activity. [PMID:9315606] |
neuropeptide Y receptor activity | molecular function | Combining with neuropeptide Y to initiate a change in cell activity. [PMID:9315606] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
neuropeptide receptor activity | molecular function | Combining with a neuropeptide to initiate a change in cell activity. [GOC:ai] |
neuropeptide binding | molecular function | Interacting selectively and non-covalently and stoichiometrically with neuropeptides, peptides with direct synaptic effects (peptide neurotransmitters) or indirect modulatory effects on the nervous system (peptide neuromodulators). [http://www.wormbook.org/chapters/www_neuropeptides/neuropeptides.html] |
Located In
This protein is located in 1 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
Active In
This protein is active in 2 target(s):
Target | Category | Definition |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
neuron projection | cellular component | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. [GOC:jl, http://www.cogsci.princeton.edu/~wn/] |
Involved In
This protein is involved in 10 target(s):
Target | Category | Definition |
outflow tract morphogenesis | biological process | The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries. [GOC:mtg_heart, UBERON:0004145] |
glucose metabolic process | biological process | The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. [ISBN:0198506732] |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation or inhibition of a nucleotide cyclase activity and a subsequent change in the concentration of a cyclic nucleotide. [GOC:mah, GOC:signaling, ISBN:0815316194] |
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | biological process | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the inhibition of adenylyl cyclase activity and a subsequent decrease in the intracellular concentration of cyclic AMP (cAMP). [GOC:dph, GOC:mah, GOC:signaling, GOC:tb, ISBN:0815316194] |
neuropeptide signaling pathway | biological process | A G protein-coupled receptor signaling pathway initiated by a neuropeptide binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. [GOC:mah, ISBN:0815316194] |
locomotory behavior | biological process | The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions. [GOC:dph] |
feeding behavior | biological process | Behavior associated with the intake of food. [GOC:mah] |
regulation of blood pressure | biological process | Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. [GOC:dph, GOC:mtg_cardio, ISBN:0721643949] |
sensory perception of pain | biological process | The series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness, so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature, mechanical damage, electricity or from noxious chemical substances. This is a neurological process. [GOC:curators] |
regulation of multicellular organism growth | biological process | Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size. [GOC:dph, GOC:ems, GOC:tb] |